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Abstract
Objective—We describe the impact of intense counseling to reduce vaginal hygiene practices 
and its effect on bacterial vaginosis (BV).
Design—Secondary data analysis of HPTN 035 trial
Setting—Seven African and one U.S. site
Population—HIV negative, non-pregnant women at least 18years old
Methods—At enrollment and during follow-up quarterly visits, vaginal hygiene practices were 
determined by face-to-face administration of a behavioral assessment questionnaire. Vaginal 
hygiene practices were categorized as insertion into the vagina of: (1) nothing; (2) water only; and 
(3) other substances with or without water. Each practice was quantified by frequency and type/
combination of inserted substances. At quarterly visits, diagnosis of BV was made using the 
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Nugent score. Trends for vaginal hygiene practices and BV were evaluated using generalized 
estimating equation models.
Results—3087 participants from the HPTN 035 study were eligible for this analysis. At 
enrollment, 1859 (60%) reported recent vaginal hygiene practices. By one year, this figure had 
decreased to 1019 (33%) with counseling. However, BV prevalence remained consistent across the 
study observation period, with 36–38% of women testing positive for the condition (p for trend= 
0.27). Overall, those who reported douching with water only (AOR= 1.03, 95%CI: 0.94 – 1.13) 
and those who reported inserting other substances (AOR= 0.98, 95%CI: 0.88 – 1.09) in the past 
quarter were not more likely to have BV compared to those who reported no insertions. However, 
in South Africa, an increase in BV was seen among those who reported inserting other substances 
(AOR: 1.48, 95%CI: 1.17, 1.88).
Conclusions—Targeted counseling against vaginal hygiene practices resulted in change in self-
reported behavior, but did not have an impact on BV diagnosis in all but one site.
Keywords
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Introduction
Vaginal hygiene practices are genital cleansing practices that women engage in to address 
perceived woman-specific needs of hygiene, sexuality, and vaginal health and treatment of 
genital symptoms.1–3 These behaviors, including physical or chemical manipulation of 
vaginal tissue by application of soaps, acetic acid, douches, or insertion of natural or 
synthetic fibers, or other efforts to change the normal environment of the vagina may result 
in changes to pH, vaginal dryness, disruption of bacterial flora, or micro-abrasions or 
erosions. These complications increase a woman’s susceptibility for infection, such as 
bacterial vaginosis (BV) and sexually transmitted infections including HIV, as well as other 
adverse gynecologic and obstetric outcomes.2, 4–11 The prevalence of vaginal hygiene 
practices is believed to be high, although estimates range from 6 to 98% in sub-Saharan 
Africa.1
A consistent association has been observed between certain vaginal hygiene practices and 
BV among women.4, 12, 13 Ness et al. found that douching was associated with twice the 
frequency of BV (OR 2.1; 95% CI 1.3–3.1), with the highest risk among women reporting 
so in the past week.12 Other studies have shown a high correlation between vaginal hygiene 
practices, including douching with soap, antiseptics, commercial douches, homemade 
solutions, and cleansing post menses as well as application of lubricants such as petrolatum 
or saliva, and BV.8,14,15
During HIV Prevention Trial Network protocol 035 (HPTN 035), a multi-center study that 
evaluated the safety and effectiveness of two candidate microbicide gels BufferGel and PRO 
2000 0.5% gel, we conducted intensive counseling to inform women of the potential 
unhealthy consequences of vaginal hygiene practices.16 Early studies of BufferGel and PRO 
2000 0.5% gel indicated that these agents were not associated with development of BV.14,17 
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In this secondary analysis, we investigated the impact of one-on-one counseling on self-
reported vaginal hygiene practices and BV. We hypothesized that a positive correlation 
would exist between vaginal practices and prevalent BV.
Methods
The design of HPTN 035 has been described previously.16 Briefly, we conducted the study 
between February 2005 and October 2008. We enrolled HIV negative, non-pregnant women 
at least 18 years old and randomized them to one of four study arms: BufferGel vaginal gel, 
PRO 2000 0.5% vaginal gel, hydroxyethylcellulose (HEC) placebo vaginal gel, or no gel/
condoms only. Participants were enrolled for a minimum of 12 months, the timing of the 
study’s primary outcome, but follow-up continued until the last participant reached this time 
point for a maximum of 30 months. The study was conducted in seven African (Blantyre, 
Malawi; Lilongwe, Malawi; Durban, South Africa; Hlabisa, South Africa; Kamwala, 
Zambia; Chitungwiza/Harare, Zimbabwe) and one U.S. site (Philadelphia, Pennsylvania). 
The trial (clinicaltrials.gov number NCT00074425) was approved and overseen by local 
ethics committees and institutional review boards at each study site. All participants 
provided written informed consent prior to participation.
At enrollment and during quarterly visits, we administered a behavioral assessment 
questionnaire to all participants, which included a detailed question regarding vaginal 
practices (Figure 1). This interview was conducted in a private setting by a trained research 
staff member, generally a nurse or other clinician, and was followed by a physical 
examination that included collection of a vaginal fluid for pH, Gram’s stain, and wet mount. 
All sites collected vaginal smears for central processing and adhered to HPTN Central 
Laboratory standards for collection, processing, labelling and transportation.16
At a later time during the same visit, participants were counseled on HIV/STI risk reduction 
and against vaginal hygiene practices. This conversation aimed to communicate several 
principals in regards to vaginal hygiene practices: (i) vaginal hygiene practices, especially 
those affecting lubrication of vaginal mucosa, could put the individual at increased risk for 
contracting HIV/AIDS, (ii) since the study utilizes vaginally applied products, it is important 
to avoid co-application of other products, (iii) vaginal hygiene practices can disrupt vaginal 
pH balance and put the woman at risk for vaginal infections, and (iv) avoiding vaginal 
hygiene practices promotes vaginal health. Specific messages were catered to an individual 
based on her responses to the questionnaire and her specific practices. This non-scripted 
counseling occurred at every contact (including unscheduled interim visits), was one-on-one 
with a nurse and/or physician, and was followed by a verbal assessment of participant 
understanding.
Our statistical analysis was designed to describe vaginal hygiene practices over time and 
evaluate their relationship to the diagnosis of BV. We included all follow-up data from 
participants, including observations past 12 months in participants enrolled for longer 
periods. Vaginal practices were categorized as follows: (1) Did not insert anything into the 
vagina; (2) insertion of water only; and (3) insertion of any other substances with or without 
water (e.g., water with vinegar, water with soap, paper, cloth, cotton or cotton wool, 
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tampons, fingers without anything else). For the last two categories, follow-on questions 
were asked to delineate frequency and type/combination of inserted substance. Diagnosis of 
BV was based on the Nugent criteria.17 The validation of the vaginal Gram stain smear 
compared with the Amsel criteria found the sensitivity and specificity was 89 and 83%, 
respectively and hence the vaginal Gram stain (Nugent criteria) was considered to be a 
sensitive method for the diagnosis of bacterial vaginosis.18 Presence of BV was defined as a 
Nugent score of 7–10 and absence of BV was defined by a Nugent score of 0–6. 
Symptomatic women diagnosed with BV (Nugent ≥7 were provided 2 grams of 
metronidazole as a single dose for treatment at the same visit as recommended.19 All 
eligible, enrolled and randomized participants in the HPTN 035 study were included in the 
analysis.
Baseline characteristics of participants were compared across the clinical sites using the Chi-
square test for independence for categorical variables, and analysis of variance for 
continuous measures. Nugent scores for BV diagnoses were represented graphically over 
time. We also examined the association between vaginal hygiene practices and BV positivity 
overall and by country using generalized estimating equations (GEE) with a logit link 
function and exchangeable working correlation structure. We ran all models, we adjusted for 
country/sites, arm assignment (BufferGel, no gel, PRO 2000/5, placebo), quarterly visit 
beginning with the first quarterly visit at 3 months through the study exit visit at 32 months, 
and potential confounders of age (in 10 year increments), education (some primary school or 
less, secondary school or more), marital status (married, has a partner or neither) and 
number of sex partners (0, 1, 2, 3 or more).
All analyses were performed using SAS Version 9.2 (SAS Institute, Cary, North Carolina, 
USA).
Results
Across the eight enrolling sites, 3,087 participants were included in the analysis. The median 
follow-up time was 20.4 months. The mean age of participants was 26.3 years (SD 6.2); 
educational status varied across countries. Nearly all participants reported being married and 
86.7% reported partner/husband providing financial support (Table 1). For all characteristics, 
statistically significant differences were observed across the countries (p<0.0001).
At baseline, out of 3087 participants, 1228 (40%) denied vaginal hygiene practices, while 
424 (14%) reported using water, and 1435 (46%) reported using various other products 
including commercial douches, vinegar and water, soap and water, paper, cloth, cotton, 
cotton wool, tampons, or fingers. The percent of participants using various vaginal hygiene 
practices is shown over time in Figure 2. Women who reported not practicing any form of 
vaginal hygiene practice increased from 40% at enrollment to 67% by 12 months 
(p<0.0001); this upward trend appeared to wane during the second year. General downward 
trends were observed for those reporting using water (p<0.0001), and other substances 
during the first year (p<0.0001).
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Alongside the self-reported behavioral data, we examined trends in BV over time as a 
biological marker influenced by vaginal hygiene practices. While frequency of BV testing 
waned after one year as patients exited the study, the proportion testing positive for BV 
remained constant (approximately 36–38%) throughout the follow-up period (Figure 3 and 
Table 2).
Overall, compared to insertion of nothing, we observed no statistically significant effects of 
water use only (AOR: 0.98; 95% CI: 0.88, 1.09; p=0.75) or use of materials or products 
other than or in addition to water (AOR: 1.04; 95% CI: 0.95, 1.13; p=0.44) on BV positivity 
after adjusting for study visit, arm assignment, age, education, marital status and number of 
sex partners (Table 3 and Figure 4). Compared to insertion of nothing, the effect of water use 
only and use of materials or products other than or in addition to water on BV positivity, 
respectively, by country were as follows: Malawi: (AOR: 0.89; 95% CI: 0.78, 1.03; p=0.12) 
and (AOR: 0.91; 95% CI: 0.80, 1.03; p=0.13); South Africa: (AOR: 0.78; 95% CI: 0.22, 
2.84; p=0.72) and (AOR: 1.48; 95% CI: 1.17, 1.88; p=0.001); U.S.A: (AOR: 0.86; 95% CI: 
0.38, 1.96; p=0.73) and (AOR: 1.16; 95% CI: 0.91, 1.48; p=0.23); Zambia: (AOR: 1.10; 
95% CI: 0.87, 1.38; p=0.43) and (AOR: 0.98; 95% CI: 0.72, 1.32; p=0.88); Zimbabwe: 
(AOR: 0.86; 95% CI: 0.62, 1.20; p=0.38) and (AOR: 0.76; 95% CI: 0.39, 1.51; p=0.44). To 
account for multiple comparisons [i.e., Two overall comparisons and two comparisons each 
for five countries (12 total)], we used a Bonferroni adjusted p-value of p < 0.004 to attribute 
meaningful statistical significance at the p < 0.05 nominal level. Therefore, in South Africa 
only, we observed increased odds of BV positivity with use of materials or products other 
than or in addition to water compared to insertion of nothing.
Discussion
In HPTN 035, self-reported vaginal hygiene practices declined among study participants 
over time. This was likely a result of the counseling provided by the study, which engaged 
and educated participants regarding the risks associated with vaginal hygiene practices. 
Interestingly, the analogous trends for BV diagnosis – our proposed surrogate marker for 
vaginal hygiene practices – did not align with the change in reported behavior.
This analysis possesses numerous strengths: conduct within a large, rigorous clinical trial 
and a generalizable population with high prevalence of studied behaviors. Nevertheless, we 
acknowledge limitations as well. First, the intervention was designed as a multifaceted 
counseling session and covered many topics on health. Due to time constraints, messages 
were covered generically but with latitude as to the “dose” of messages for each particular 
participant. While it is probable that every participant received counseling against vaginal 
hygiene practices at every visit, there may have been variability in the amount of time 
helping each participant understand the reasons for changing behavior or to discuss 
alternatives and skills to help individuals change their behavior. This could have resulted in a 
superficial understanding on part of the participant, which may have resulted in a reduction 
but not cessation of high-risk practices. Second, while the analysis is very robust in the first 
12–15 months, participation in study declined as participants exited study in the second year. 
This could affect our ability to distinguish changes in trends during the latter follow-up 
period. Finally, we do not have data available to determine which cases of BV were treated, 
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i.e., which were symptomatic, to know if subsequent cases of BV were incident cases or 
whether they were persistent BV from previous episodes. Treatment was only for 
symptomatic cases; therefore, the previously diagnosed asymptomatic cases could 
potentially contribute to the BV cases at the next assessment. This could have diluted the 
effect of positive behavior change that did occur, as untreated BV acquired during previous 
time periods (i.e. prior behavior) would be attributed falsely during later time points when 
counseling could have been having its impact. This would have influenced the result toward 
the null hypothesis, that there was no impact of change in vaginal hygiene practices on BV 
acquisition, when in fact change did occur, and observed subsequent BV was prevalent, not 
incident. Furthermore, the relapse rate of BV in these circumstances is approximately 20 to 
50% following treatment, which would occur regardless of ongoing behavior change in 
regards to vaginal hygiene practice.20
Other studies have found similar results. Most were smaller and vulnerable to biases 
resulting from self-report – as in the current study – but they did lead to the development of 
an individualized counseling approach acknowledging the perceived benefits and risks of 
vaginal hygiene practices. Notably, Masese et al. used an information-motivation framework 
including individualized skills teaching and harm reduction to encourage participants to 
reduce or eliminate vaginal washing. They found a reduction in self-report of vaginal 
hygiene practices but no significant changes on biological markers, including prevalence of 
BV.20 Similarly, other groups have shown impact of individualized counseling on self-
reported behaviors but no conclusive evidence that those changes in behavior led to 
reductions in BV.3, 21, 22 Our discordant findings suggest that either the link identified 
between vaginal hygiene practices and BV is not causal or, self-reported behavior change is 
an unreliable method to assess changes in this behavior. We did note one exception to this 
overall finding. When we conducted stratified analysis of South African data, we found that 
counseling around vaginal practices – in particular, products other than or in addition to 
water – was associated with BV. This result is in line with our original hypothesis and 
reiterates the potential for heterogeneity between populations. It is unlikely that retention or 
adherence to gel could have caused this difference as both were high and similar at all 
sites.16
Self-reported behavior change in our study could have been influenced by social desirability 
bias. Data on vaginal hygiene practices was collected through face-to-face interviews. While 
this is an effective means for counseling, data collection could have been more reliable if 
ascertained through less personal means, such Audio Computer Assisted Self Interview 
(ACASI). ACASI was not used in this study. It has been known to capture some sensitive 
behaviors more reliably in high- risk populations and standardizes data collection.23,24 
While an over-estimation of actual change in vaginal hygiene practices could partially 
explain the result, it is also possible that our expectation that compliance to the counseling 
would be cessation of vaginal hygiene practices altogether was not the interpretation of the 
participants. Perhaps this explains why there are some who changed their behavior only in 
terms of frequency or type of inserts. Despite its association with our exposure of interest, it 
is also possible that BV may not be the ideal biological marker to assess changes in vaginal 
hygiene practices.
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Taken together, these findings highlight some of the challenges involved with evaluating 
change within behavioral interventions, especially those of a sensitive nature in which there 
are currently no reliable biological proxies to measure. These findings advocate for use of 
more rigorous ways to evaluate personal behaviors and in the development of better 
objective and biological markers for monitoring these behaviors.24
Conclusions
Intense and continuous counseling against vaginal hygiene practices such as occurred in the 
HPTN 035 trial was associated with improvements in self-reported behaviors but the trends 
of BV were not affected, even in the context of a rigorously conducted clinical trial. These 
data illustrate the potential difficulties in modifying and measuring behavior within the 
realm of reproductive health. However, this study has demonstrated that nesting these types 
of behavioral interventions within larger trials, such as HIV prevention trials, may provide 
an avenue with sufficient statistical power to answer these questions in the future. Outcomes 
of such may inform the design of public health strategies to reduce behavioral practices 
potentially harmful to health.
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Figure 1. 
Vaginal hygiene practice questions
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Figure 2. 
Vaginal hygiene practices reported in last month by study visit
Kasaro et al. Page 10
Int J STD AIDS. Author manuscript; available in PMC 2017 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 3. 
Distribution of bacterial vaginosis according to study visit
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Figure 4. 
Proportion of women with bacterial vaginosis over time according to reported vaginal 
hygiene practice
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